Header Logo

Connection

Rami Doukky to Risk Factors

Back to Details
This is a "connection" page, showing publications Rami Doukky has written about Risk Factors.
Rami Doukky
Connection Strength
2.211
Risk Factors
  1. Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta-analysis. Clin Cardiol. 2021 May; 44(5):675-682.
    View in: PubMed
    Score: 0.116
  2. The Prognostic Value of MPI in CKD: Can we do better? J Nucl Cardiol. 2022 Feb; 29(1):155-157.
    View in: PubMed
    Score: 0.116
  3. Impact of pretransplant mitral annular calcification on the incidence of cardiac events after renal transplantation. Nephrol Dial Transplant. 2020 03 01; 35(3):526-533.
    View in: PubMed
    Score: 0.108
  4. Myocardial perfusion imaging and coronary calcium score: A marriage made in heaven. J Nucl Cardiol. 2021 10; 28(5):2097-2099.
    View in: PubMed
    Score: 0.106
  5. The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates. BMC Cardiovasc Disord. 2019 05 02; 19(1):102.
    View in: PubMed
    Score: 0.102
  6. Use of ultrasound enhancing agents in transesophageal echocardiography to improve interpretive confidence of left atrial appendage thrombus. Echocardiography. 2019 02; 36(2):362-369.
    View in: PubMed
    Score: 0.099
  7. Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease. Clin Cardiol. 2018 May; 41(5):660-665.
    View in: PubMed
    Score: 0.095
  8. Validation of a clinical pathway to assess asymptomatic renal transplant candidates using myocardial perfusion imaging. J Nucl Cardiol. 2018 12; 25(6):2058-2068.
    View in: PubMed
    Score: 0.089
  9. Safety of stress testing in patients with elevated cardiac biomarkers: Are all modalities created equal? J Nucl Cardiol. 2017 04; 24(2):735-737.
    View in: PubMed
    Score: 0.082
  10. Impact of Physical Inactivity on Mortality in Patients With Heart Failure. Am J Cardiol. 2016 Apr 01; 117(7):1135-43.
    View in: PubMed
    Score: 0.081
  11. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2016 Jan 16; 14:4.
    View in: PubMed
    Score: 0.081
  12. Appropriate use criteria for SPECT myocardial perfusion imaging: Are they appropriate for women? J Nucl Cardiol. 2016 08; 23(4):695-705.
    View in: PubMed
    Score: 0.079
  13. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016 06; 23(3):560-9.
    View in: PubMed
    Score: 0.079
  14. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging. J Nucl Cardiol. 2015 Aug; 22(4):700-13.
    View in: PubMed
    Score: 0.077
  15. Effective risk stratification of patients on the basis of myocardial perfusion SPECT is dependent on appropriate patient selection. Curr Cardiol Rep. 2015 Jan; 17(1):549.
    View in: PubMed
    Score: 0.076
  16. Coronary Computed Tomographic Angiography in the Evaluation of Liver Transplant Candidates. Angiology. 2015 Oct; 66(9):803-10.
    View in: PubMed
    Score: 0.075
  17. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge. Int J Chron Obstruct Pulmon Dis. 2014; 9:129-37.
    View in: PubMed
    Score: 0.071
  18. Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging. Circulation. 2013 Oct 08; 128(15):1634-43.
    View in: PubMed
    Score: 0.069
  19. The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease. J Nucl Cardiol. 2013 Oct; 20(5):774-84.
    View in: PubMed
    Score: 0.069
  20. A simple validated clinical tool to predict the absence of coronary artery disease in patients with systolic heart failure of unclear etiology. Am J Cardiol. 2013 Oct 15; 112(8):1165-70.
    View in: PubMed
    Score: 0.068
  21. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013 Sep; 30(8):889-95.
    View in: PubMed
    Score: 0.067
  22. The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
    View in: PubMed
    Score: 0.066
  23. Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.
    View in: PubMed
    Score: 0.066
  24. Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression. Acta Cardiol. 2023 Sep; 78(7):778-789.
    View in: PubMed
    Score: 0.034
  25. Risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review. J Invasive Cardiol. 2002 Apr; 14(4):215-20.
    View in: PubMed
    Score: 0.031
  26. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart. 2020 07; 106(14):1043-1045.
    View in: PubMed
    Score: 0.027
  27. Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement. EuroIntervention. 2020 Apr 17; 15(17):1497-1505.
    View in: PubMed
    Score: 0.027
  28. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Cochrane Database Syst Rev. 2019 12 20; 12:CD013319.
    View in: PubMed
    Score: 0.027
  29. Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 08; 96(2):413-421.
    View in: PubMed
    Score: 0.026
  30. Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR. J Cardiovasc Magn Reson. 2018 12 20; 20(1):87.
    View in: PubMed
    Score: 0.025
  31. Association between lifetime risk of atrial fibrillation and mortality in the oldest old. Clin Cardiol. 2018 May; 41(5):634-639.
    View in: PubMed
    Score: 0.024
  32. Lipoprotein(a) and Increased Cardiovascular Risk in Women. Clin Cardiol. 2016 Feb; 39(2):96-102.
    View in: PubMed
    Score: 0.020
  33. Outcomes after inappropriate nuclear myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol. 2016 08; 23(4):680-9.
    View in: PubMed
    Score: 0.020
  34. Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2010 May; 88(2):189-95.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.